NSCI

NANALYSIS ANNOUNCES UP TO $5.0 MILLION BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND UP TO $1.0 MILLION CONCURRENT PRIVATE PLACEMENT

Retrieved on: 
Wednesday, March 6, 2024

There is an offering document relating to the Offering that can be accessed under the Company's profile at www.sedarplus.ca and at www.nanalysis.com .

Key Points: 
  • There is an offering document relating to the Offering that can be accessed under the Company's profile at www.sedarplus.ca and at www.nanalysis.com .
  • Prospective investors should read this offering document before making an investment decision.
  • The Company will also be simultaneously conducting a concurrent brokered "best efforts" prospectus exempt offering of Units of the Company, on the same terms as the Offering, for gross proceeds of up to approximately $1,000,000 by way of a private placement.
  • Certain insiders of the Company may participate in the Concurrent Offering.

Nanalysis Announces Upcoming Webinar and Conference Participation

Retrieved on: 
Wednesday, February 7, 2024

CALGARY, AB, Feb. 7, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, announces that Founder and CEO Sane Krakiwsky will be participating in an upcoming webinar and conference.

Key Points: 
  • CALGARY, AB, Feb. 7, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, announces that Founder and CEO Sane Krakiwsky will be participating in an upcoming webinar and conference.
  • The webinar will be a live, interactive online event where attendees are invited to ask the Company questions in real-time following the interview.
  • An archived webcast will be made available for those who cannot join the event live on the day of the webinar.
  • Management will also be available on February 14th and 15th for one-on-one meetings which can be requested through the conference site.

Nanalysis Achieves Record Revenue in Q4

Retrieved on: 
Tuesday, February 6, 2024

CALGARY, AB, Feb. 6, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, provides an estimate of Q4 2023 unaudited revenue and highlights some other recent business accomplishments.

Key Points: 
  • CALGARY, AB, Feb. 6, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, provides an estimate of Q4 2023 unaudited revenue and highlights some other recent business accomplishments.
  • Sean Krakiwsky, Founder and CEO of Nanalysis, states: "We are very pleased with how the fourth quarter closed out 2023, a year not without its challenges.
  • With both Benchtop NMR and Security Services contributing significantly, we were able to achieve fourth quarter unaudited revenues of between $9.3MM and $9.8MM, constituting a new record quarter for Nanalysis.
  • New Quarterly Revenue Record: Q4 2023 revenue will be at least $9.3MM (unaudited), driven by continued expansion of security services related to the Company's airport security maintenance project, as well as continued recovery in Benchtop NMR sales.

Nanalysis Scientific Corp. Provides Update on Security Services Business

Retrieved on: 
Tuesday, January 30, 2024

Phase-In of Canada-Wide Coverage at All 89 Designated Airports Completed on January 11, 2024

Key Points: 
  • Phase-In of Canada-Wide Coverage at All 89 Designated Airports Completed on January 11, 2024
    CALGARY, AB, Jan. 30, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, gives an update on its subsidiary K'(Prime) Technologies ("KPrime") security services business and the five-year $160 million contract with Canadian Air Transport Security Authority ("CATSA").
  • "Having now taken over all preventative and corrective maintenance services for CATSA, we expect the project to begin generating positive EBITDA in Q1 2024*.
  • This approach will position us to expand the capabilities and opportunities for our Security Services business with other customers and partners."
  • After completion of initial training, the Company expects lower ongoing training costs commensurate with ordinary staff turnover and ongoing certification maintenance.

Nanalysis Scientific Corp. Announces Grant of Restricted Share Units

Retrieved on: 
Thursday, January 4, 2024

CALGARY, AB, Jan. 3, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ( TSXV:NSCI , OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted 475,000 Restricted Share Units ("RSU"s) to its independent Directors, pursuant to the Company's RSU plan.

Key Points: 
  • CALGARY, AB, Jan. 3, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ( TSXV:NSCI , OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted 475,000 Restricted Share Units ("RSU"s) to its independent Directors, pursuant to the Company's RSU plan.
  • Each RSU is exercisable for one common share in the capital of the Company for a period ending at the end of the calendar year, three years after the date of grant.
  • 100,000 of the RSUs vest immediately, and the remaining RSUs vest as to one-third on each of the 12-month, 24-month, and 36-month anniversary of the date of grant.

Nanalysis Reports Third Quarter 2023 Results

Retrieved on: 
Wednesday, November 29, 2023

CALGARY, AB, Nov. 29, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its third quarter results ending September 30, 2023.

Key Points: 
  • CALGARY, AB, Nov. 29, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its third quarter results ending September 30, 2023.
  • "We had a good third quarter with continued strength in Security Services and we are encouraged by the results we are seeing in Benchtop Sales NMR with a 61% improvement sequentially over Q2, 2023," said Sean Krakiwsky Founder and CEO of Nanalysis.
  • Gross profit margins on product sales were 43% for the three months ended September 30, 2023.
  • There was continued training for the CATSA project that began in the first quarter of 2023, resulting in net training expenses of $689K for the three months ending September 30, 2023, and $2,580K for the nine months ending September 30, 2023 .

Nanalysis Announces Third Quarter 2023 Conference Call

Retrieved on: 
Wednesday, November 15, 2023

Hosting Call at 5:00 pm ET on Wednesday, November 29th

Key Points: 
  • Hosting Call at 5:00 pm ET on Wednesday, November 29th
    CALGARY, AB, Nov. 15, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines and MRI technology for industrial and research applications announces that on Wednesday, November 29th, 2023, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter ending September 30, 2023.
  • Investors interested in participating in the live full year call can dial 1-888-664-6392 or 416-764-8659 from abroad.
  • Investors can also access the call online through a listen-only webcast here: https://app.webinar.net/r3VaMyOQbg1 or on the investor relations section of the Company's website HERE .
  • The webcast will be archived on the Company's investor relations webpage for at least 90 days and a telephonic playback will be available for seven days after the conference call by calling 1-888-390-0541 or 416-764-8677, conference ID # 964847.

Nanalysis to Present at the Planet MicroCap Showcase: VANCOUVER 2023 on Wednesday, September 6, 2023 & 1x1 Meetings on Thursday, September 7, 2023

Retrieved on: 
Wednesday, August 30, 2023

CALGARY, AB, Aug. 30, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines and MRI technology for industrial and research applications announces that it will be presenting at the Planet MicroCap Showcase: VANCOUVER 2023 on Wednesday, September 6, 2023 at 9:30 AM PST.

Key Points: 
  • CALGARY, AB, Aug. 30, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines and MRI technology for industrial and research applications announces that it will be presenting at the Planet MicroCap Showcase: VANCOUVER 2023 on Wednesday, September 6, 2023 at 9:30 AM PST.
  • CEO and Founder Sean Krakiwsky will be hosting the presentation and answering questions at the conclusion.
  • To access the live presentation, please use the following information:
    If you would like to book 1x1 investor meetings with CEO Sean Krakiwsky and to attend the Planet MicroCap Showcase: VANCOUVER 2023, please make sure you are registered here: https://planetmicrocapshowcase.com/signup
    1x1 meetings will be scheduled and conducted in person at the conference venue: Fairmont Waterfront Vancouver (BC).
  • The Planet MicroCap Showcase: VANCOUVER 2023 website is available here: https://planetmicrocapshowcase.com/
    If you can't make the live presentation, all company presentations "webcasts" will be available directly on the conference event platform on this link under the tab "Agenda": https://planetmicrocapshowcase.com/agenda

Nanalysis Reports Second Quarter 2023 Results

Retrieved on: 
Thursday, August 24, 2023

CALGARY, AB, Aug. 24, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its second quarter results ending June 30, 2023.

Key Points: 
  • CALGARY, AB, Aug. 24, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its second quarter results ending June 30, 2023.
  • "Our topline results of $6,956k in sales is encouraging on a sequential and year over year basis," said Sean Krakiwsky Founder and CEO of Nanalysis.
  • 3rd Party Equipment: Second quarter sales grew 52% over Q1 2023, though still trailed behind Q2 2022 sales.
  • This represents costs related to anticipated headcount reductions that will take place over the rest of 2023, primarily during the third quarter.

Nanalysis Announces Second Quarter 2023 Conference Call

Retrieved on: 
Tuesday, August 15, 2023

Hosting Call at 5:00 pm ET on Thursday, August 24th

Key Points: 
  • Hosting Call at 5:00 pm ET on Thursday, August 24th
    CALGARY, AB, Aug. 15, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company"), ( TSXV: NSCI) ( OTCQX: NSCIF) ( FRA: 1N1 ), a leader in portable NMR machines and MRI technology for industrial and research applications announces that on Thursday, August 24th, 2023, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter ending June 30, 2023.
  • Investors interested in participating in the live full year call can dial 1-888-664-6392 or 416-764-8659 from abroad.
  • Investors can also access the call online through a listen-only webcast here: https://app.webinar.net/mbeN7MlYQon or on the investor relations section of the Company's website HERE .
  • The webcast will be archived on the Company's investor relations webpage for at least 90 days and a telephonic playback will be available for seven days after the conference call by calling 1-888-390-0541 or 416-764-8677, conference ID #309928.